Search PubMed⌕ Search

Biomedical subjects

B J Feery

Publications and source records attributed to B J Feery.

29 records · Page 2Linked to original sources
PubMed1977

Immunization with influenza vaccine in patients with haematological malignant disease.

Fifty-eight patients with a variety of haematological lymphoproliferative or myeloproliferative disorders were given bivalent subunit influenza virus vaccine, and their antibody responses after vaccination were compared with those of a normal control group. Although geometric mean titres of the patient group showed lower initial antibody levels, smaller increments, and lower final titres, after vaccination 83% of this group achieved satisfactory antibody levels to the A/Pt Chalmers strain, and 57% to the B/Hong Kong strain. The lowest antibody levels and smallest responses occurred in patients with non-Hodgkin's lymphoma, Hodgkin's disease, and multiple myeloma. Four of seven patients who showed low antibody levels, and no response to the first injection, responded to a second dose.

Adult↗
PubMed1977

Recurrent venous thrombosis with a "lupus" coagulation inhibitor in the absence of systemic lupus.

A young man presenting with recurrent deep venous thrombosis was found to have a lupus type coagulation inhibitor. He showed neither clinical nor serological evidence of systemic lupus. The value of the Russell viper venom coagulation time in the detection of the inhibitor is demonstrated. Anticoagulant therapy has not caused any bleeding complication despite the presence of the inhibitor.

Adult↗
PubMed1976

Streptococcal sore throat in general practice--a controlled study.

A controlled study was undertaken to determine the incidence of Group A haemolytic streptococci and other bacterial pathogens in throat swabs from patients presenting with sore throats. The isolation rate (38-8%) of Group A haemolytic streptococci from patients with acute tonsillitis was significantly higher than the isolation rate (8-9%) in a control group, but there was no significant difference in the isolation rates in patients diagnosed as having acute pharyngitis compared with the control group. There was no difference in the isolation rates of the other bacterial pathogens in the patient and control groups. In-vitro antibiotic studies were performed, and a comparison was made of the results of these tests and the treatment prescribed.

Acute Disease↗
PubMed1976

Antibody response to one and two doses of influenza virus subunit vaccine.

Antibody studies were undertaken to evaluate the responses after one and two-dose schedules of influenza immunization with subunit influenza vaccine. The responses were studied in two adult population groups after the administration of a vaccine containing the most recent epidemic strains A/Pt Chalmers/73 and B/Hong Kong/8/73. Responses to the A component of the vaccine were greater than those to the B strain. Patients with initially low antibody levels responded better than those with higher levels. There was little additional benefit from the second dose of vaccine.

Adult↗
PubMed1976

The specificity of nematode allergens in the diagnosis of human visceral larva migrans.

Extracts of nematodes have been used as skin test antigens in the diagnosis of nematode infections for many years. Ascaris lumbricoides and Toxocara canis are two nematodes commonly involved in human parasitism, the latter being associated with the clinical condition of Visceral Larva Migrans. In vitro and in vivo experiments reported in this paper confirm experimentally, as well as clinically, the existence of cross-reacting antigens between T. canis and Ascaris spp., and probably between T. canis and other nematodes. These cross-reactions compromise the usefulness of skin tests in the diagnosis of such parasitic infections.

Allergens↗
PubMed1976

The efficacy of vaccinial immune globulin. A 15-year study.

This survey reports on the use of vaccinial immune globulin in Australia over the last 15 years. Evidence is produced that vaccinial immune globulin has proven efficacious in the prophylaxis and therapy of complications following smallpox vaccination. An indication of the type and frequency of complications following vaccination is provided.

Eczema↗
PubMed1976

The conquest of smallpox.

Smallpox has been a dreaded disease for thousands of years. Recurrent epidemics traversed the known world leaving a trail of death, disfigurement, and disability unparalleled by the other great plagues. Fear of smallpox provoked the first important attempts to prevent epidemic disease by a primitive form of immunization called variolation. In 1796, Edward Jenner developed the first effective vaccine against an infectious disease by using cowpox virus to prevent subsequent infection with smallpox. The discovery of this vaccine made possible the conquest of smallpox, a task that will probably be completed this year.

Adolescent↗
PubMedDate not supplied

Influenza immunization in adults with diabetes mellitus.

The antibody responses to influenza vaccination of a group of adult diabetic patients were compared with responses in a healthy group of regular volunteer vaccinees. The initial and final geometric mean hemagglutination-inhibiting antibody titers were lower in the patient group, but the relative increase in titers was greater for each of the vaccine components. The percentage of fourfold rises in individual titers was greater in the diabetic group than in the control group. It was concluded that patients with diabetes mellitus responded normally to influenza vaccination. This was confirmed in an additional study. There was no significant difference in the antibody responses of patients treated with insulin or oral antidiabetic agents. There was no impairment of diabetic control as a result of influenza vaccination when this was evaluated by measuring the concentration of glycosylated hemoglobin, or by random blood glucose estimations. There was no significant change in the serum insulin level after immunization in patients on oral diabetic agents. It was concluded that influenza vaccination was safe and effective in adult diabetic patients.

Adult↗